Navigation Links
ImpactRx Releases 2010 Oncology Promotion Report

MOUNT LAUREL, N.J., Jan. 31, 2011 /PRNewswire/ -- ImpactRx, a pioneer in tracking and evaluating pharmaceutical promotion on the prescribing behavior of physicians, completed its annual review of the detailing efforts of pharmaceutical/biotech sales representatives in oncology offices.  The results have just been published in the January 2011 edition of Oncology Business Review.

ImpactRx's mobile pharmaceutical market research system offers a longitudinal network of 475 oncologists who use iPhone technology and proprietary software to provide real-time data about sales representative promotion, meeting and event participation and patient treatment options.  This year the data was supplemented with research into physicians' online behavior provided through a joint offering ImpactRx has with comScore, a global leader in measuring digital traffic and readership.  The result is a unique view of the promotional landscape in the fast-paced and ever-changing oncology market, helping pharmaceutical companies make the most of every minute with key physicians.

According to Richard Altus, President and CEO of ImpactRx, "Given the recent changes in the pharmaceutical and biotech industries, face time with oncologists is more valuable than ever.  This data helps refine brand and targeting strategies to ensure that the right message gets to the right physicians, providing an optimized and powerful marketing strategy."

Click here  to download "The 3rd Annual Outlook on the Pharmaceutical Promotional Landscape within Oncology".

Key data highlighted in the article includes:

  • Share of Attention – Sales Representative Oncology Product Details 2006-2010
  • Top 25 Products Detailed by Sales Representatives 2009/2010
  • Oncology Sales Force Top Tier Rating 2010
  • Reach of Healthcare Websites  (Jan – Sept 2010)
  • Average Number of Visits per Month (Jan – Sept 2010)

  • About ImpactRx

    Founded in 2000 and headquartered in Mount Laurel, NJ, ImpactRx's longitudinal panel of high prescribing, smart phone-connected physicians is the exclusive source of continuously captured promotion and treatment data.  Through its proprietary methodology, the Company captures annually one million details and three million treatment decisions, fueling its unique industry database.  ImpactRx leverages this unprecedented intelligence with custom research and analytics to provide insightful solutions to pharmaceutical marketing and sales decision makers.  Visit ImpactRx at AguilarSagefrog Marketing Group,

    SOURCE ImpactRx
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. ImpactRx Tracks Decline in Zetia and Vytorin Prescribing
    2. Kantar Health and ImpactRx Launch CancerMPact Monthly Drugs and Regimens for Oncology Business Decisions
    3. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
    4. CEL-SCI Corporation Releases Letter to Shareholders
    5. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
    6. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
    7. Immunosyn Corporation Releases SF-1019 Study Results
    8. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
    9. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
    10. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
    11. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
    Post Your Comments:
    (Date:10/13/2015)... World Thrombosis Day Interactive Infographic ...   --> World Thrombosis Day Interactive ... promote vital global awareness of thrombosis, its causes, ... the formation of potentially deadly blood clots in ... thromboembolism (VTE) - or the artery (arterial thrombosis) [1] ...
    (Date:10/12/2015)... the United States . By early next year, ... the United States . By early next year, ... The University of Texas MD Anderson Cancer Center, Elekta and ... Tesla) MRI-guided linear accelerator in the United States ... a non-clinical capacity. Royal Philips (NYSE: PHG ...
    (Date:10/12/2015)... , Oct. 12, 2015 ... the setbacks and the needs of the medical membrane ... of membrane devices within the different medical membrane devices ... blood microfilters/apheresis systems and membrane diagnostic devices. - Gain ... in this market. --> Use this report ...
    Breaking Medicine Technology:
    (Date:10/13/2015)... ... October 13, 2015 , ... According to an ESPN ... orbital fracture when a teammate accidentally elbowed him in the left eye during the ... injury is just one of a series of setbacks, including a knee injury that ...
    (Date:10/13/2015)... ... October 13, 2015 , ... ... as the newest professional to introduce the latest development, ThermiVa® temperature controlled radiofrequency ... a leading professional in Obstetrics and Gynecology and a pioneer in the field ...
    (Date:10/13/2015)... , ... October 13, 2015 , ... ... Affinity have developed valuable new strategies for enrolling and serving insurance consumers who ... to obtain health insurance and pay monthly premiums. In “Health Plan Engagement Strategies: ...
    (Date:10/13/2015)... ... October 13, 2015 , ... ... the Florida Apartment Association (FAA) has partnered with the Florida Department of Health ... demand. , The FAA Smoke-Free Multifamily Housing Program launched last week at ...
    (Date:10/13/2015)... ... ... Just under three months ago, eMarketing Concepts forever changed the ... offering all of their services for just a buck in the first month. The ... calls from interested buyers. As a genuine one-stop-shop for internet marketing, EMC has cornered ...
    Breaking Medicine News(10 mins):